Instem is a contributing partner in the VICT3R Consortium, a collaborative initiative exploring the use of Virtual Control Groups (VCGs) in toxicology studies.
Instem and VICT3R: Pioneering Ethical Innovation in Toxicology Studies
read more
SEND Archives
Keep up to date with the latest news and events from Instem.
When should we start worrying about SEND v4.0?
Begin considering the systems that collect and report those data and how they may be connecting to your SEND tools. CROs will have far more data and study types that are now modelled in SEND.
Goodbye XPT files, hello Dataset-JSON!
There has been a lot of buzz around Dataset-JSON for a while now, and so, like any responsible vendor, we have been keeping a close eye on the development of the standard.
Live SEND Webinar featuring Instem’s Marc Ellison
The Past, Present, and Future of SEND: The Continuing Evolution of Our Nonclinical Standard
What changes can we expect for the SEND world in 2025?
Read the latest from our Sensible SEND blog.
Sensible SEND – Supporting Smart People with Smart Science
Read the latest blog from Marc Ellison, Director, SEND Solutions, Instem.
SEND: Everything You Need to Know
Adapting to these changes can be challenging, but early adoption and thoughtful implementation lead to improved research efficiency.
Reusing SEND Data for ICH S1B Submissions: Faster, Cost-Effective Carcinogenicity Assessments
In this article, we explore how SEND data can be used in data gathering for WoE submissions and the key time and cost benefits for sponsors looking to streamline their submissions.
SENDIG-GeneTox v1.0: What You Need to Know
Preparing your regulatory team for the new SENDIG-GeneTox requirements.
Meet the Experts at Instem—SEND Edition!
Meet Marc Ellison, Director, SEND Solutions, Instem.
Empower Your Research
Start Your Transformation Today